GSK:LON
GSK plc
1.759,00 GBX
arrow_downward
−1,15%(−20,50) 1D
5. okt., 16:36:51 GMT +1 · GBX
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za GSK …
Odpri
1.786,50 GBX
Visoka
1.790,00 GBX
Nizka
1.755,00 GBX
Tržna kapitalizacija
94,05 mrd.
Povprečni promet
5,45 mio.
Promet
3,78 mio.
Dividenda
3,87 %
Četrtletna dividenda
17,00 GBX
Prvi trgovalni dan brez upravičenja do dividende
13. avg. 2026
Razmerje med ceno delnice in čistim dobičkom
14,91
52-tedenski najvišji tečaj
2.282,00 GBX
52-tedenski najnižji tečaj
1.592,00 GBX
Čisti dobiček na delnico
1,18 GBX
Št. izdanih delnic
4,05 mrd.
Št. zaposlenih
67 tis.
Odpri
1.786,50 GBX
Visoka
1.790,00 GBX
Nizka
1.755,00 GBX
Tržna kapitalizacija
94,05 mrd.
Povprečni promet
5,45 mio.
Promet
3,78 mio.
Dividenda
3,87 %
Četrtletna dividenda
17,00 GBX
Prvi trgovalni dan brez upravičenja do dividende
13. avg. 2026
Razmerje med ceno delnice in čistim dobičkom
14,91
52-tedenski najvišji tečaj
2.282,00 GBX
52-tedenski najnižji tečaj
1.592,00 GBX
Čisti dobiček na delnico
1,18 GBX
Št. izdanih delnic
4,05 mrd.
Št. zaposlenih
67 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Traders Union
·
pred 13 urami
Why is GSK stock flat today? Resistance levels in focus
AD HOC NEWS
·
pred 4 meseci
GSK stock after-hours at EUR 20.74: minus 0.43 percent versus prior close
Profil
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Vizitka: GSK plc
Generalni direktorEmma Walmsley | Emma Walmsley
Št. zaposlenih66,8 tis.
Ustanovljeno27. dec. 2000
Sedež-
Sektor-
Spletno mestogsk.com